Skip to main content
Log in

Post-transplant diabetes mellitus associated with heart and lung transplant

  • Original Article
  • Published:
Irish Journal of Medical Science (1971 -) Aims and scope Submit manuscript

Abstract

Background

The incidence of post-transplant diabetes (PTDM) is variable primarily due to a lack of standardised diagnostic criteria.

Aim

This study aimed to assess the incidence of PTDM in heart and lung transplant (HLT) patients and to review if the management of these patients is in accordance with the 2014 American Society of Transplantation guidelines.

Methods

This was a retrospective study in the Mater Misericordiae University Hospital, Dublin, Ireland. Data was collected from the patients who had undergone HLT.

Results

All patients who had a heart and/or lung transplant between 2005 and 2017 were identified. The majority of our patients had lung 111 (53.9%), heart 94 (45.6%) and combined heart/lung 1(0.5%) transplants. A total of 174 (84.5%) patients were screened for diabetes pre-transplantation. Two hundred five (99.9%) patients were screened for PTDM post-surgery. The cumulative incidence for PTDM was 19.4% (40/206). All patients with PTDM were on prednisolone, 32 (80%) on tacrolimus and 4 (10%) on cyclosporine.

Conclusions

The cumulative incidence of post-transplant diabetes in our cohort was 19.4%. The majority of the patients were screened before and after transplant for glucose abnormality. The authors recommend that all patients should be managed in a multidisciplinary setting including transplant physicians, endocrinlogist, diabetes nurse specialists, transplant nurses and dietitians.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ (2003) Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 3(2):178–185

    Article  Google Scholar 

  2. Reisaeter AV, Hartmann A (2001) Risk factors and incidence of posttransplant diabetes mellitus. Transplant Proc 33(5A Suppl):8S–18S

    Article  CAS  Google Scholar 

  3. Davidson J, Wilkinson A, Dantal J et al (2003) New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation 75(10 Suppl):SS3–S24

    PubMed  Google Scholar 

  4. Stratton IM, Adler AI, Neil HA et al (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 321(7258):405–412

    Article  CAS  Google Scholar 

  5. Chaturvedi N, Bandinelli S, Mangili R, Penno G, Rottiers RE, Fuller JH (2001) Microalbuminuria in type 1 diabetes: rates, risk factors and glycemic threshold. Kidney Int 60(1):219–227

    Article  CAS  Google Scholar 

  6. Fowler MJ (2008) Microvascular and macrovascular complications of diabetes. Clinical Diabetes 26(2):77–82

    Article  Google Scholar 

  7. Burroughs TE, Swindle J, Takemoto S, Lentine KL, Machnicki G, Irish WD, Brennan DC, Schnitzler MA (2007) Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients. Transplantation. 83(8):1027–1034

    Article  Google Scholar 

  8. Moore R, Ravindran V, Baboolal K (2006) The burden of new-onset diabetes mellitus after transplantation. Clin Transpl 20(6):755–761

    Article  Google Scholar 

  9. Sharif A, Hecking M, de Vries AP et al (2014) Proceedings from an international consensus meeting on post transplantation diabetes mellitus: recommendations and future directions. Am J Transplant 14(9):1992–2000

    Article  CAS  Google Scholar 

  10. Mazali FC, Lalli CA, Alves-Filho G, Mazzali M (2008) Posttransplant diabetes mellitus: incidence and risk factors. Transplant Proc 40(3):764–766

    Article  Google Scholar 

  11. Park SC, Yoon YD, Jung HY, Kim KH, Choi JY, Park SH, Kim CD, Kim YL, Kim HK, Huh S, Cho JH (2015) Effect of transient post-transplantation hyperglycemia on the development of diabetes mellitus and transplantation outcomes in kidney transplant recipients. Transplant Proc 47(3):666–671

    Article  Google Scholar 

  12. Hecking M, Haidinger M, Döller D, Werzowa J, Tura A, Zhang J, Tekoglu H, Pleiner J, Wrba T, Rasoul-Rockenschaub S, Mühlbacher F, Schmaldienst S, Druml W, Hörl WH, Krebs M, Wolzt M, Pacini G, Port FK, Säemann MD (2012) Early basal insulin therapy decreases new-onset diabetes after renal transplantation. J Am Soc Nephrol 23(4):739–749

    Article  CAS  Google Scholar 

  13. Woodward RS, Schnitzler MA, Baty J, Lowell JA, Lopez-Rocafort L, Haider S, Woodworth TG, Brennan DC (2003) Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant 3(5):590–598

    Article  Google Scholar 

  14. Lindholm A, Albrechtsen D, Frödin L, Tufveson G, Persson NH, Lundgren G (1995) Ischemic heart disease--major cause of death and graft loss after renal transplantation in Scandinavia. Transplantation. 60(5):451–457

    Article  CAS  Google Scholar 

  15. Johnston SD, Morris JK, Cramb R, Gunson BK, Neuberger J (2002) Cardiovascular morbidity and mortality after orthotopic liver transplantation. Transplantation. 73(6):901–906

    Article  Google Scholar 

  16. Jindal RM, Sidner RA, Milgrom ML (1997) Post-transplant diabetes mellitus. The role of immunosuppression. Drug Saf 16(4):242–257

    Article  CAS  Google Scholar 

  17. Cosio FG, Kudva Y, van der Velde M, Larson TS, Textor SC, Griffin MD, Stegall MD (2005) New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation. Kidney Int 67(6):2415–2421

    Article  Google Scholar 

  18. Ghisdal L, Van Laecke S, Abramowicz MJ, Vanholder R, Abramowicz D (2012) New-onset diabetes after renal transplantation: risk assessment and management. Diabetes Care 35(1):181–188

    Article  CAS  Google Scholar 

  19. Vincenti F, Friman S, Scheuermann E, Rostaing L, Jenssen T, Campistol JM, Uchida K, Pescovitz MD, Marchetti P, Tuncer M, Citterio F, Wiecek A, Chadban S, el-Shahawy M, Budde K, Goto N, on behalf of the DIRECT (Diabetes Incidence after Renal Transplantation: Neoral® C2 Monitoring Versus Tacrolimus) Investigators (2007) Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant 7(6):1506–1514

    Article  CAS  Google Scholar 

  20. Cosio FG, Larson TS (2003) Cardiovascular disease after transplantation: do we know all of the variables? Am J Transplant 3(8):915–916

    Article  Google Scholar 

  21. James PA, Oparil S, Carter BL et al (2014) 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC). JAMA 311(5):507–520

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors would like to thank the patients involved in this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mensud Hatunic.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kgosidialwa, O., Blake, K., O’Connell, O. et al. Post-transplant diabetes mellitus associated with heart and lung transplant. Ir J Med Sci 189, 185–189 (2020). https://doi.org/10.1007/s11845-019-02068-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-019-02068-7

Keywords

Navigation